JAK2 and hepatocellular carcinoma: A separate analysis of the mutually independent roles of JAK2 and SRC in downstream signaling activation and cell fate, similar to studies done in pre-adipocytes and human hepatoma cells [32, 120], would be of interest and value to resolve in further studies.